Jacobs & CO Novartis Ag Transaction History
Jacobs & CO
- $1 Billion
- Q3 2024
A detailed history of Jacobs & CO transactions in Novartis Ag stock. As of the latest transaction made, Jacobs & CO holds 2,750 shares of NVS stock, worth $266,282. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,750
Previous 2,750
-0.0%
Holding current value
$266,282
Previous $292,000
8.22%
% of portfolio
0.03%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding NVS
# of Institutions
1,438Shares Held
133MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.18 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.16 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$784 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$676 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$559 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $208B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...